Authority of Drug Enforcement Administration Supervisory Diversion Investigators, Field Intelligence Managers, and Intelligence Group Supervisors To Sign and Issue Administrative Subpoenas
Key claim: The DEA is expanding authority to sign and issue administrative subpoenas under the Controlled Substances Act to Supervisory Diversion Investigators, Field Intelligence Managers, and Intelligence Group Supervisors.
Abstract
(Rule · Justice Department) The Drug Enforcement Administration (“DEA”) is revising the Appendix to Department of Justice regulations that contains delegations of certain functions under the Controlled Substances Act and its implementing regulations. This rule authorizes additional DEA personnel, specifically Supervisory Diversion Investigators, Field Intelligence Managers, and Intelligence Group Supervisors, to sign and issue administrative subpoenas.
Why this matters
DEA administrative subpoenas are a primary investigative tool used against registrants — prescribers, pharmacies, distributors, and manufacturers of controlled substances — to obtain records without court approval. Expanding signing authority to additional supervisory ranks increases the operational capacity for diversion and intelligence investigations, which can affect how quickly providers and pharmacies encounter compliance demands. The change is procedural rather than substantive, but it shifts the day-to-day interface between DEA and the regulated healthcare community.